kabutan

STELLA PHARMA, Apr-Dec (Cumulative 3Q) Net Income Loss Widens, Oct-Dec Net Income Loss Widens

Thu Feb 12, 2026 2:00 pm JST Earnings

4888 STELLA PHARMA CORPORATION 【J-GAAP】

Earnings Report

STELLA PHARMA CORPORATION <4888> [TSE Growth] announced its financial results in the afternoon session on February 12th (14:00). The net loss (non-consolidated) for the cumulative third quarter of the fiscal year ending March 2026 (April to December) expanded to a loss of 512 million yen (compared to a loss of 373 million yen in the same period last year).

Based on the cumulative third-quarter performance announced by the company and the unchanged full-year plan, our calculation indicates that the net income/loss for the January to March period (4Q) is expected to turn into a loss of 399 million yen (compared to a profit of 233 million yen in the same period last year).

In the most recent three-month period, from October to December (3Q), the net loss expanded to a loss of 205 million yen (compared to a loss of 105 million yen in the same period last year). The operating profit/loss margin drastically worsened from -124.7% in the same period last year to -350.8%.

Kabutan News

Actual Results

Accumulated Results 3rd Quarter
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Progress Rate vs. First Half Announce Accounting Standards
Apr - Dec, 2023 200 -466 -466 -469 -15.2 ー Feb 13, 2024 J-GAAP
Apr - Dec, 2024 254 -375 -371 -373 -11.3 ー Feb 12, 2025 J-GAAP
Apr - Dec, 2025 261 -512 -509 -512 -15.1 ー Feb 12, 2026 J-GAAP
YoY +2.8% -36.5% -37.2% -37.3% -33.5%

Current Period Guidance

Second Half Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Oct - Mar, 2024 792 179 130 128 3.9 0 May 9, 2025 J-GAAP
Oct - Mar, 2025 Guidance 177 -624 -602 -604 -17.8 0 Nov 13, 2025 J-GAAP
YoY -77.7% － － － －

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2024 269 -760 -760 -763 -24.7 0 May 10, 2024 J-GAAP
Mar, 2025 961 -90 -137 -140 -4.2 0 May 9, 2025 J-GAAP
Mar, 2026 Guidance 377 -922 -908 -911 -26.8 0 Oct 14, 2025 J-GAAP
YoY -60.8% -924.4% -562.8% -550.7% -534.6%

Quarterly Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Oct - Dec, 2024 85 -106 -104 -105 -3.2 -124.7 Feb 12, 2025 J-GAAP
Jan - Mar, 2025 707 285 234 233 7.0 40.3 May 9, 2025 J-GAAP
Apr - Jun, 2025 92 -151 -155 -156 -4.6 -164.1 Aug 7, 2025 J-GAAP
Jul - Sep, 2025 108 -147 -151 -151 -4.5 -136.1 Nov 13, 2025 J-GAAP
Oct - Dec, 2025 61 -214 -203 -205 -6.0 -350.8 Feb 12, 2026 J-GAAP
YoY -28.2% -101.9% -95.2% -95.2% -90.2%

Related Articles